Sapindus mukorossi

Other Names

Antuvala kayiAreethaArishtaArishtakArishtakaAristhaArithaArithoBara ritaChinese soapberryDoadniDodaDodanEnmei-hiFeizaojiaHaithagutiHrishtahIndian soapberryKanmarKunkuduKunkum ChettuManmarNorekaayiPannankottaiPhenakaPhenilaRaksha beejaReethaRishtahRitaRithaRithanSapindus abruptusSapindus acuminatusSapindus boninensisSapindus detergensSapindus emarginatusSapindus indicusSapindus mukorossi var. carinatusSapindus oocarpusSapindus polyphyllusSapindus utilisSarishtaSoap nutSoap-nut treeSoap-nut tree of North IndiaSoapberrySoapkaayiSoapnutSoapnut treeThaliTree of Northern IndiaUristaVenalWash nutWashnutWu-huan-ziWuhuangziYouzhuzi

Synopsis

Sapindus mukorossi (Soapnut / Reetha)

1. Identity, Taxonomy, and Natural Source

Sapindus mukorossi Gaertn. is a deciduous tree belonging to the family Sapindaceae. The genus Sapindus comprises three major species: the American species Sapindus saponaria and two Asian species, Sapindus mukorossi and Sapindus trifoliatus, all well known for their folk medicinal values. S. mukorossi is commonly referred to by a variety of vernacular names depending on region: soapnut, soapberry, reetha, ritha, aritha, wash nut, and Wu Huan Zi (in Chinese traditional medicine).

Sapindus mukorossi, commonly known as soapnut or aritha, is a deciduous tree found in the upper reaches of the Indo-Gangetic plains, Shivaliks, and sub-Himalayan tracts. The species is distributed in tropical and sub-tropical regions of Asia. In Vietnam, for example, S. mukorossi is a common species whose fruits have been used as soap for a long time; the species is widely distributed in almost all provinces of low mountainous regions (under 1000 m) and midlands.

Morphologically, the color of the stem bark is greenish/pale-gray to brown; leaves are paripinnate, with 5 to 15 cm long lanceolate leaflets; flowers are bisexual, small, and in terminal compound panicles; flowering occurs in May–June and fruits ripen during October–November on a leafless tree; fruits are globose and fleshy, changing in colour from yellow-orange to dark brown upon ripening. The pericarp makes up 56% of the S. mukorossi fruit, and the fruit also contains a seed covered by a hard, black shell with kernel pulp inside.

Common Preparations and Dosage Forms

The plant is used in several physical forms across traditional and contemporary applications:

Dried fruit pericarp (shell): the most pharmacologically studied part, used as powder, decoction, or aqueous extract.
Seed oil (kernel oil): extracted from the seed kernel and used topically for skin and oral health applications.
Aqueous extract: prepared from leaf and stem material, studied for antitumor properties.
Saponin-standardized extract: used in contraceptive cream formulations and cosmetics.
Intravaginal cream: the CONSAP formulation (a 2.5% cream derived from pericarp saponins) and Praneem polyherbal cream, both developed for contraceptive use.
Shampoo / topical cleanser: pericarp extract used as a natural surfactant in hair and skin products.
Powdered seeds: used in traditional dental and internal applications.

2. Traditional and Historical Use

Being one of the world's oldest cultivated medicinal plants, Sapindus boasts various therapeutic uses; its use has been traced back to the period of Ancient India, estimated to be around 5,000 years ago. The application of S. mukorossi (known in Chinese as Wu Huan Zi) seed kernel for antimicrobial and skin care is recorded in China's traditional pharmaceutical book, the Compendium of Materia Medica (Bencao Gangmu), some 500 years ago.

Ayurveda and South Asian Traditions

The fruit pericarps are used for treating asthma, migraine, skin diseases (eczema, psoriasis, pimples, freckles, dandruff), and psychiatric disorders (hysteria, epilepsy) in Ayurveda and folklore medicine. The pericarp of S. mukorossi has been traditionally used as an expectorant as well as a source of natural surfactant; due to the presence of saponins, soapnut is well known for its detergent and insecticidal properties, and was traditionally used for removing lice from the scalp and in dental caries.

In Ayurveda, S. mukorossi is widely used to remove freckles as well as to treat epilepsy; it is traditionally used to remove lice from the scalp, to cure excessive salivation, migraines, and as a contraceptive. The powdered seeds are used to cure dental problems, common cold, arthritis, nausea, and constipation. The leaves are used in baths to relieve joint pains.

Traditional Use Across Asia

Plants of the genus Sapindus have been used in traditional medicine for the treatment of ulcers, external wounds, inflammation, epilepsy, dental caries, arthritis, joint pain, gout, and rheumatism. In Chinese traditional medicine, the tree's pericarp and seed kernel have long served as topical antimicrobials and skin-cleansing agents. In Vietnam, the plant is cultivated in communal houses, pagodas, and around villages for its fruit load and shade.

3. Key Phytoconstituents and Active Compounds

Phytochemical studies of Sapindus plants have identified more than 103 compounds, including flavonoids, triterpenoids, glycosides, carbohydrates, fatty acids, phenols, fixed oil, and saponins. Of these compounds, saponins are regarded as the active group most likely responsible for the observed biological effects.

Triterpenoidal Saponins

The main phytoconstituents isolated and identified from different parts of this plant are triterpenoidal saponins of oleanane, dammarane, and tirucullane type. Of these compounds, triterpenoidal saponins of oleanane, dammarane, and tirucullane are regarded as the active group most likely responsible for the observed biological activities. The specific saponin glycosides include the sapindosides (sapindoside A and sapindoside B), the mukoroziosides, and the sapinmusaponins. Sapindoside A has been shown to be hederagenin 3-O-α-L-arabinosyl-(2→1)-α-L-rhamnopyranoside and sapindoside B is the 3-O-α-L-arabopyranosyl-(2→1)-O-α-L-rhamnopyranosyl-(3→1)-β-D-xylopyranoside.

The major constituents in the fruit are saponins (approximately 10.0–11.5%) and sugars (10%). Six new fatty esters of tetracyclic triterpenoid together with a known acyclic sesquiterpenoidal glycoside have been isolated from the fruits of Sapindus mukorossi.

Sesquiterpene Oligoglycosides

Previous phytochemical studies have demonstrated that S. mukorossi contains the main chemical constituents of triterpenoid saponins and sesquiterpene oligoglycosides; the plant extracts exhibited various biological effects such as antibacterial and antifungal activity. A phytochemical investigation of S. mukorossi pericarps yielded six acyclic sesquiterpene glycosides, including three new compounds named mukuroziosides A–C.

Flavonoids

The leaves of S. mukorossi contain flavonoids such as quercetin, apigenin, kaempferol, and rutin. These phenolic compounds contribute to antioxidant activity documented in stem bark fractions.

Seed Oil Constituents

The seed contains approximately 23% oil with 92% triglycerides; the triglyceride fraction contains approximately 30% oleo-palmitoarachidin glyceride, 13.3% oleo-diarachidin glyceride, and 56.7% di-olein type glyceride. The seed oil also contains the non-glyceridic component cyanolipid (1-cyano-2-hydroxymethyl prop-1-ene-3-ol). However, since the composition of S. mukorossi oil is very similar to that of S. trifoliatus oil but without the toxic cyanolipids, it is considered pharmacologically relevant that S. mukorossi seed kernel oil may provide pharmaceutical effects without the adverse effect of cyanolipid. The seed oil contains abundant monounsaturated fatty acids, β-sitosterol, and δ-tocopherol, which are beneficial for wound healing.

Trypsin Inhibitor Protein

A notable non-saponin constituent is the soapnut trypsin inhibitor (SNTI). Molecular docking and in vitro studies of soapnut trypsin inhibitor (SNTI) have been conducted against phospholipase A2 isoforms in the context of therapeutic intervention of inflammatory diseases.

4. Mechanisms of Action

The diverse biological activities of S. mukorossi are primarily attributed to its saponin fraction, operating through several distinct mechanisms:

Membrane disruption (surfactant/detergent action): Triterpenoid saponins are natural amphiphilic molecules that interact with and destabilize biological membranes. The antifungal activity of S. mukorossi extracts against Venturia inaequalis and Botrytis cinerea was linked to the hemolytic/membranolytic potential of its saponins. The same mechanism underlies spermicidal and anti-Trichomonas activities.
Spermicidal membrane action: Saponin disrupts the actin cytoskeleton network beneath the cell membrane and affects membrane-mediated adherence of Trichomonas to the host cells.
Anti-inflammatory pathways: Soapnut trypsin inhibitor has been studied via molecular docking against phospholipase A2 isoforms for therapeutic intervention in inflammatory diseases.
Anticancer/antitumor signaling: Gene and protein expression studies indicated that aqueous extract treatment altered the expression of proliferation/survival modulator NF-κB, tumor growth modulator ERK2, metastasis-associated molecules MMP9/12, and tumor suppressor p53 in A549 cells.
Antibiotic bioenhancement: In vitro research demonstrated that the conjugated treatment of bacterial cells with polymyxin B (PMB) and S. mukorossi extract enhanced bacterial total membrane permeability compared to PMB alone; for the S. aureus strain, a significant decrease in viability was noted, associated with a significant increase in cell membrane permeability.
Hepatoprotective mechanisms: Antioxidant properties at the cellular level appear to underpin liver protection against chemical injury, as evidenced by in vitro and in vivo models using CCl4-induced liver damage.

5. Scientific Evidence by Area of Use

5.1 Spermicidal and Contraceptive Activity

This is the most clinically advanced area of research for S. mukorossi, with evidence extending into Phase III human trials.

The saponin-rich fraction was shown to exhibit spermicidal activity through complete immobilization of human ejaculated spermatozoa with a minimum effective concentration (MEC) of 0.5 mg/mL.

Building on in vitro and animal data, a clinical program was established in India. The fruits of the herb contain saponins that showed excellent spermicidal activity in vitro and in vivo animal experiments; a cream formulation was prepared for human application, and a safety and tolerability pilot clinical study was organized to evaluate the contraceptive safety and efficacy of 2.5% cream when used intravaginally before coitus. Women volunteers were instructed to use 2.5% CONSAP cream in a loading dose of 3 g, 5–7 minutes before coitus, and to present themselves for a post-coital test the next morning; the study was conducted on 27 women volunteers at two centres; the post-coital test showed immobile spermatozoa in vaginal and endocervical aspirates.

A local contraceptive preparation incorporating the active ingredient from the fruit pericarp of Sapindus mukorossi has successfully completed Phase III clinical trials in India and is ready for marketing. Hindustan Latex Limited, Mumbai, licensed the cream to market as a non-hormonal herbal spermicidal contraceptive.

A polyherbal formulation, Praneem, also incorporates S. mukorossi. Praneem, a combination of seed extract of Azadirachta indica, fruit extract of Sapindus mukorossi, and Mentha citrata oil, has emerged as an intravaginal polyherbal cream and pessary; the formulation was safe under sub-acute toxicity studies in monkeys and has demonstrated effective contraceptive efficacy in rabbits and monkeys after intravaginal application.

Evidence strength: Moderate-to-strong for spermicidal effect. In vitro data are consistent and replicated across multiple laboratories. Animal data are supportive. One Phase III human clinical trial has been completed, and the formulation is commercially licensed in India — this represents the highest level of clinical evidence reported for any application of S. mukorossi. No large published randomized controlled trial (RCT) comparing CONSAP against conventional spermicides has been identified in the peer-reviewed literature outside of the described clinical program.

5.2 Antimicrobial Activity

Many studies have shown that the pericarp of the S. mukorossi fruit has positive biological effects, including fungicidal and anti-microbial activities; more recent studies have indicated that S. mukorossi extract exhibits significant anti-microbial activities and could potentially be used as a source of agents to cure dental caries and for skin care; these studies have clearly shown that the major anti-bacterial effect is from saponins extracted from the fruit's pericarp.

Against the acne-causing pathogen Cutibacterium acnes: The extract solvent and procedure were screened based on saponin yield and minimum inhibitory concentration (MIC); the optimized fermentation and ethyl acetate extract had the highest yield of saponins (7.83 ± 0.26%) and the best antibacterial activity (MIC = 0.125 mg/mL) against C. acnes; the destroyed bacterial cell membrane and wall were observed by transmission electron microscopy, which resulted in cell lysis and death.

Against Helicobacter pylori: Ethanol and chloroform extracts of Sapindus mukorossi inhibited the growth of Helicobacter pylori (both susceptible and resistant strains) at very low concentrations when given orally to male Wistar rats for 7 days.

Against fungi: Sapindus mukorossi saponins inhibited in vitro mycelial growth of Botrytis cinerea and gray mold on strawberry fruit in a dose-dependent manner; this inhibitory effect was attributed to impairment in membrane potential and integrity, induction of autophagic-like vacuoles, and disturbance in organellar homeostasis.

The seed oil also demonstrated direct antimicrobial effects. The seed oil has significant anti-inflammatory and anti-microbial activities against Propionibacterium acnes, S. aureus, and C. albicans (inactivation rate >99.9%); S. mukorossi seed oil also promotes cell proliferation and migration capability.

Evidence strength: Substantial in vitro evidence across multiple bacterial and fungal species. In vivo animal data support some findings. Human clinical evidence is limited; no controlled clinical trials in humans specifically for antimicrobial endpoints have been identified.

5.3 Anti-Trichomonas Activity

The Sapindus saponin mixture shows anti-Trichomonas activity at a 10-fold lower concentration (0.005%) than its minimal effective spermicidal concentration. Saponins produced no adverse effect on host cells in the mitochondrial reduction potential measurement assay; saponin disrupts the actin cytoskeleton network beneath the cell membrane and affects membrane-mediated adherence of Trichomonas to the host cells.

Evidence strength: In vitro only. The selectivity for the parasite over host cells at low concentrations is a notable pharmacological finding, but clinical translation has not been established separately from contraceptive studies.

5.4 Anti-inflammatory, Analgesic, and Antipyretic Activity

Anti-inflammatory effects of the leaves of S. mukorossi have been studied using carrageenan-induced paw edema in rats. A study published in a peer-reviewed journal evaluated the stem bark: anti-inflammatory (carrageenan-induced paw edema), analgesic (hot plate latency test), and antipyretic (rectal temperature) activities were determined in Sprague-Dawley rats; quantitative estimation of total phenolic contents in extract/fractions varied between 252.3 ± 2.41 mg of GAE/g and 594.16 ± 4.3 mg of GAE/g.

Evidence strength: Pre-clinical (rodent) only. No human clinical trials have been identified specifically for inflammatory conditions. In vitro and animal evidence is consistent but requires clinical validation.

5.5 Hepatoprotective Activity

In a study aimed at investigating the hepatoprotective capacity of S. mukorossi and Rheum emodi extracts in CCl4-treated male rats, the dried powder was extracted successively with petroleum ether, benzene, chloroform, and ethanol; primary rat hepatocyte monolayer cultures were used for in vitro studies; the hepatoprotective capacity of the extract of the fruit pericarp of S. mukorossi was analyzed in liver-injured CCl4-treated male rats. Extracts of Sapindus mukorossi (2.5 mg/L) have been reported to have a protective capacity both in vitro on primary hepatocyte cultures and in vivo in a rat model of CCl4-mediated liver injury, as judged from serum marker enzyme activities.

Antioxidant effects of S. mukorossi extract against CCl4-induced liver cirrhosis have been studied in rats.

Evidence strength: Pre-clinical (in vitro and rodent) only. No human clinical evidence is available for hepatoprotection.

5.6 Anticancer / Antitumor Activity

S. mukorossi has been demonstrated to be antitumoral against several types of tumor, including liver carcinomic Hepa59T/VGH cells, large lung carcinomic NCI cells, cervical epithelioid carcinomic HeLa cells, medulloblastoma Med/Daoy, colon adenocarcinomic WiDr cells, and oral epidermoid carcinomic KB cells.

A study published in Scientific Reports (2018) examined aqueous extract from leaves and stems: the aqueous extract (SaM) contained two polysaccharides mainly made of myo-inositol, galactose, glucose, and fructose; in vitro treatment of SaM diminished the proliferative potential of lung adenocarcinomic cells and induced intracellular oxidative stress, as well as necrotic cell death; moreover, exposure to SaM attenuated cell migration, demonstrating effectiveness at reducing the invasive property of malignant lung cells. Using model animals bearing Lewis lung cancer cell LL/2, it was demonstrated that SaM was antitumoral and did not induce any undesired organ damage, immunotoxicity, or off-target inflammation.

Evidence strength: Preclinical only — in vitro cell lines and one in vivo murine tumor model. No human oncology trials have been identified. The findings are preliminary and hypothesis-generating.

5.7 Anxiolytic and Antiepileptic Activity

Extract of S. mukorossi has exhibited anxiolytic activity in mice, and antiepileptic activity has been studied in rats. In the anxiolytic study: the anxiolytic activity of methanolic extract of Sapindus mukorossi was evaluated in mice using Elevated Plus Maze, Y-maze, Hole-board, Actophotometer, and Marble-burying behavior models; the efficacy of the extract (200 and 400 mg/kg) was compared with the standard anxiolytic drugs Diazepam (2 mg/kg) and Fluoxetine (10 mg/kg); the result showed that the extract significantly increased the number of entries and time spent in the open arm in the elevated plus maze.

Evidence strength: Pre-clinical animal studies only. Traditional use for epilepsy and hysteria is documented, but no human clinical evidence for neurological endpoints has been identified.

5.8 Antihyperglycemic and Antihyperlipidemic Activity

Extract obtained from the fruit of S. mukorossi strongly exhibited anti-hyperglycemic and anti-hyperlipidemic activities in streptozotocin-induced diabetic rats, and the extract was also able to restore the haematological and histopathological changes of pancreas towards those of normal rats.

Evidence strength: Pre-clinical animal studies only. No human trials for metabolic endpoints have been identified.

5.9 Wound Healing (Seed Oil)

S. mukorossi seed oil contains abundant monounsaturated fatty acids, β-sitosterol, and δ-tocopherol, which are beneficial for wound healing; additionally, the oil has significant anti-inflammatory and anti-microbial activities against P. acnes, S. aureus, and C. albicans (inactivation rate >99.9%); S. mukorossi seed oil also promotes cell proliferation and migration capability. The seed oil of S. mukorossi has been found to be effective in healing skin wounds; a study on seed oil extract confirmed antibacterial, anti-inflammatory, antioxidant, cell proliferation, and skin wound healing properties.

Research using a ligature-induced periodontitis rat model found: the distance between cementoenamel junction (CEJ) and alveolar bone crest (ABC) on the sagittal micro-CT slide showed that total bone loss (TBL) was significantly lower in CEJ-ABC distances between the S. mukorossi oil and S. mukorossi oil-free groups on Day 14.

Evidence strength: In vitro and animal models. No controlled human clinical trials for wound healing have been identified.

5.10 Oral and Dental Health

The Sapindus mukorossi extract has been reported to possess antibacterial, antifungal, anti-inflammatory, and antioxidant characteristics. Studies have explored the potential use of the extract as an alternative root canal irrigant: given the challenges associated with sodium hypochlorite (NaOCl), numerous studies have explored the effectiveness of herbal agents as alternatives for root canal irrigation. In an in vitro investigation, pulp tissue samples were extracted from human teeth (collectively weighing 144 mg) and divided equally, then activated by manual digital agitation or ultrasonic irrigation for three 30-second cycles with a resting period of 45 seconds between each activation.

Evidence strength: Laboratory (in vitro) only for endodontic applications. No clinical dental trials have been identified.

5.11 Antibiotic Potentiation

Current research has elucidated the novel field of utilizing S. mukorossi extracts to magnify the biocidal efficacy of polymyxin B, offering insights into its in vitro mechanisms of action against S. aureus, S. epidermidis, P. aeruginosa, and E. coli; findings demonstrate the potentiating antimicrobial action of SM extract and polymyxin B against pathogenic bacterial strains and highlight the potential for reducing the environmental footprint of PMB.

Evidence strength: In vitro only. An early-stage finding with potential clinical relevance given antibiotic resistance concerns, but requiring substantial further development.

5.12 Anti-Acne Activity

A 2025 study in ScienceDirect investigated in vivo anti-acne effects: previous studies confirmed the antibacterial activity of Sapindus saponins against Cutibacterium acnes; however, the anti-acne activity in vivo and related cellular targets of Sapindus saponins were not fully established; a subsequent study aimed to investigate the anti-acne effects in vivo and the action mechanism of the saponin fraction using network pharmacology, transcriptomic analysis, and microbiome integration.

Evidence strength: Primarily in vitro and animal/mechanistic studies. A 2021 double-blind clinical trial comparing a soapnut extract shampoo versus ketoconazole shampoo for mild seborrheic dermatitis has been referenced in some review literature, but the full publication has not been located in peer-reviewed databases with confirmable details at this writing.

6. Body Systems and Health Areas of Association

Reproductive system: Spermicidal and contraceptive use (clinically tested); anti-Trichomonas vaginalis activity.
Skin and integument: Wound healing (seed oil), antimicrobial activity against skin pathogens (P. acnes, S. aureus), antifungal activity, traditional use in eczema, psoriasis, dandruff, and freckles.
Oral and dental: Antibacterial against dental caries pathogens, exploration as root canal irrigant, periodontitis prevention model (animal).
Liver / hepatic system: Hepatoprotective effects in CCl4-injured animal models.
Metabolic / endocrine: Antihyperglycemic and antihyperlipidemic effects in diabetic animal models.
Neurological: Anxiolytic effects in mouse models; antiepileptic effects studied in rats; traditional use for hysteria and epilepsy.
Oncology (preclinical): Antitumor activity against multiple cancer cell lines in vitro; antitumoral effect in murine lung cancer models.
Respiratory: Traditional use as expectorant; preliminary lung cancer cell-line research.
Parasitology: Anti-Trichomonas activity; molluscicidal activity (targeting intermediate hosts of Fasciola gigantica).

7. Dosages Reported in Studies

All dosages below are as explicitly reported in identified sources. No standard therapeutic dose has been established in humans for most indications.

Contraceptive cream (CONSAP), intravaginal: 2.5% cream formulation; women volunteers used a loading dose of 3 g, 5–7 minutes before coitus.
Spermicidal minimum effective concentration (MEC), in vitro: Complete immobilization of human ejaculated spermatozoa achieved at a MEC of 0.5 mg/mL.
Hepatoprotective (in vivo, rat): Fruit pericarp extract at 2.5 mg/L demonstrated protective capacity in CCl4-injured rat liver.
Anxiolytic (in vivo, mice): Methanolic extract tested at 200 mg/kg and 400 mg/kg body weight, compared against Diazepam (2 mg/kg) and Fluoxetine (10 mg/kg).
Saponin content of fruit pulp: The pulp has a saponin content of approximately 10–11%, making it a valuable source for saponin extraction.
Antibacterial MIC against C. acnes (in vitro): MIC = 0.125 mg/mL for the optimized fermentation and ethyl acetate extract.
Anti-Trichomonas (in vitro): Sapindus saponin mixture shows anti-Trichomonas activity at 0.005% concentration.

8. Safety Considerations

Preclinical Toxicology

A dedicated toxicological study of saponins extracted from S. mukorossi Gaertn for cosmetic use was published in 2015. The study investigated acute oral toxicity, acute dermal toxicity in SPF rats, and dermal irritation in rabbits; the acute oral toxicity test showed that the LD50 of saponins from Sapindus mukorossi is 9,260 mg/kg (95% confidence interval: 6,360–13,500 mg/kg) in one sex group and 7,940 mg/kg (95% confidence interval: 4,890–12,900 mg/kg) in another; acute dermal toxicity LD50 was greater than 5,000 mg/kg in both female and male Wistar rats; dermal irritation test in rabbits showed an average score of dermal irritation per day of zero after 14 days of continuous dermal exposure. According to the classification standard of toxicity in the Hygienic Standard for Cosmetics (2002 version), the sample was classified as "practical nontoxic" and "non dermal irritation"; thus, the saponin extraction from S. mukorossi Gaerth was concluded to be safe for cosmetics.

Ocular Irritation

Direct contact with the eyes has been noted as a concern in some traditional use contexts, consistent with the well-known irritant potential of concentrated saponin solutions on mucous membranes.

Cyanolipid-Free Profile vs. Related Species

While S. trifoliatus seed extract contains cyanolipids which are irritating or toxic to human skin, the composition of S. mukorossi oil is very similar but without the toxic cyanolipids, making it a more pharmacologically attractive candidate for pharmaceutical applications.

Host-Cell Selectivity of Saponins

An important safety finding in the context of contraceptive and anti-parasitic use: saponins produced no adverse effect on host cells in the mitochondrial reduction potential measurement assay at effective anti-Trichomonas concentrations, suggesting a selective toxicity profile. Similarly, in the murine antitumor study, SaM (aqueous extract) did not induce any undesired organ damage, immunotoxicity, or off-target inflammation.

Piscicidal Activity — Ecological Consideration

The pericarp of Sapindus mukorossi is the most toxic part to fish, yielding 100% mortality within 12 hours; LD10, LD50, and LD100 range between 3.5 ppm and 10 ppm at 48 hours. This property is relevant to environmental disposal of concentrated pericarp extracts into aquatic systems.

Molluscicidal Potency

Sapindus mukorossi fruit pericarp has been identified as a potential source of botanical molluscicides against Lymnaea acuminata. This specific biological activity further underscores the broad membrane-disrupting potency of the saponins and the need for appropriate concentration management in any application.

Gaps in Long-Term Safety Data

Long-term safety studies of oral ingestion in humans have not been identified in the peer-reviewed literature. The available human evidence is largely confined to the intravaginal contraceptive application, where the CONSAP clinical program demonstrated acceptable tolerability in the studied population. Clinical evidence for internal use (e.g., laxative effects) remains scarce; additionally, more work is required to standardize extraction methods, as products can vary widely in active compound levels.

References

Health Conditions

Health conditions that Sapindus mukorossi may help support.

No conditions available.

Body Systems

Body systems that Sapindus mukorossi may help support.

No body systems available.